ArticleRSC medicinal chemistry2025

Design, synthesis and evaluation of pyrimidinobenzylamide and pyrimidinothiophenamide derivatives as inhibitors of DOT1L and related epigenetic targets DNMT3a, PRMT4 and other HMTs.

Oscar Omar Castillo-Aguilera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.